The Brazilian pharmaceutical market is the largest in Latin America, a position we expect it to maintain and solidify over our forecast period and thus drive foreign investment in the market - despite drug pricing challenges. We calculate that pharmaceutical sales in Brazil reached a value of BRL78.7bn (USD24.7bn) in 2017, accounting for 1.2% of GDP and 12.6% of health expenditure. Patented drug sales represented the largest segment of the market at 47.4% of overall sales, with a value of BRL37.3bn (USD10.7bn). Medicine spending per capita was calculated to be just USD118 in 2017.

Key View

SWOT

Industry Forecast

Industry Risk/Reward Index

Regulatory Development

Market Overview

Competitive LandscapeCompany Profile

Brazil Demographic Outlook.

Pharmaceuticals & Healthcare Glossary 

Pharmaceuticals & Healthcare Methodology